Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults. Read more about Clinical, radiologic, and genetic characteristics of histone H3 K27M-mutant diffuse midline gliomas in adults.
Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Read more about Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.
Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival. Read more about Histopathologic findings in malignant peripheral nerve sheath tumor predict response to radiotherapy and overall survival.
Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis. Read more about Awake craniotomy for resection of supratentorial glioblastoma: a systematic review and meta-analysis.
Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02. Read more about Phase I/II study of sorafenib in combination with erlotinib for recurrent glioblastoma as part of a 3-arm sequential accrual clinical trial: NABTC 05-02.
12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT. Read more about 12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT.
Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis. Read more about Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis.
Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Read more about Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma.
Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression. Read more about Temporospatial genomic profiling in glioblastoma identifies commonly altered core pathways underlying tumor progression.
Impact of the Patient Protection and Affordable Care Act on 1-year survival in glioblastoma patients. Read more about Impact of the Patient Protection and Affordable Care Act on 1-year survival in glioblastoma patients.
